Daniel Anaya
Associate Director, MS&T Ray Therapeutics
Seminars
Tuesday 27th October 2026
AAV Gene Therapy Case Study: Building an Overall Raw Material Control Strategy
9:45 am
- Setting up a simple and structured raw material risk approach suitable for small and growing organizations
- Prioritizing testing and qualification effort when time, data, and resources are limited
- Assessing risk early to avoid downstream delays and rework
